Enhanced vitamin K expenditure as a major contributor to vitamin K deficiency in COVID-19
Jazyk angličtina Země Kanada Médium print-electronic
Typ dokumentu časopisecké články
PubMed
36511328
PubMed Central
PMC9616484
DOI
10.1016/j.ijid.2022.10.030
PII: S1201-9712(22)00569-0
Knihovny.cz E-zdroje
- Klíčová slova
- COVID-19, Dp-ucMGP, Elastic fibers, Matrix Gla Protein, Vitamin K,
- MeSH
- biologické markery MeSH
- COVID-19 * MeSH
- extracelulární matrix - proteiny MeSH
- lidé MeSH
- nedostatek vitaminu K * komplikace MeSH
- proteiny vázající vápník MeSH
- SARS-CoV-2 MeSH
- vitamin K MeSH
- výdaje na zdravotnictví MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- biologické markery MeSH
- extracelulární matrix - proteiny MeSH
- proteiny vázající vápník MeSH
- vitamin K MeSH
OBJECTIVES: Vitamin K deficiency consistently associates with worse clinical outcome in COVID-19 patients. However, whether this is due to increased expenditure during inflammation or poor vitamin K status prior to infection remained unknown. METHODS: Dp-ucMGP levels of 128 individuals were measured for the post-MONICA study and were compared to SARS-CoV-2 PCR testing results. RESULTS: Dp-ucMGP levels prior to COVID-19 infection were not significantly different comparing PCR-negative, PCR-positive and not hospitalized, and PCR-positive and hospitalized patients. CONCLUSION: In this study, we demonstrate normal vitamin K status prior to infection in SARS-CoV-2 positive patients, supporting the theory of increased utilisation during disease.
Department of Internal Medicine Canisius Wilhelmina Hospital Nijmegen The Netherlands
Department of Internal Medicine University Hospital of Pilsen Pilsen Czech Republic
Department of Pulmonary Medicine Canisius Wilhelmina Hospital Nijmegen The Netherlands
Zobrazit více v PubMed
Cífková R, Bruthans J, Wohlfahrt P, Krajčoviechová A, Šulc P, Jozífová M, et al. 30-year trends in major cardiovascular risk factors in the Czech population, Czech Monica and Czech post-Monica, 1985–2016/17. PLoS One. 2020;15 PubMed PMC
Desai AP, Dirajlal-Fargo S, Durieux JC, Tribout H, Labbato D, McComsey GA. Vitamin K & D deficiencies are independently associated with COVID-19 disease severity. Open Forum Infect Dis. 2021;8:ofab408. PubMed PMC
Dofferhoff ASM, Piscaer I, Schurgers LJ, Visser MPJ, van den Ouweland JMW, de Jong PA, et al. Reduced vitamin K status as a potentially modifiable risk factor of severe coronavirus disease 2019. Clin Infect Dis. 2021;73:e4039–e4046. PubMed PMC
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. PubMed PMC
Irwin MN, Adie S, Sandison K, Alsomairy SA, Brancaccio A. Warfarin dose requirements in adults hospitalized with COVID-19 infection: a retrospective case series. J Pharm Pract. 2022;35:654–660. PubMed
Janssen R, Visser MPJ, Dofferhoff ASM, Vermeer C, Janssens W, Walk J. Vitamin K metabolism as the potential missing link between lung damage and thromboembolism in coronavirus disease 2019. Br J Nutr. 2021;126:191–198. PubMed PMC
Linneberg A, Kampmann FB, Israelsen SB, Andersen LR, Jørgensen HL, Sandholt H, et al. The association of low vitamin K status with mortality in a cohort of 138 hospitalized patients with COVID-19. Nutrients. 2021;13:1985. PubMed PMC
Mayer O, Jr Seidlerová J, Wohlfahrt P, Filipovský J, Vaněk J, Cífková R, et al. Desphospho-uncarboxylated matrix gla protein is associated with increased aortic stiffness in a general population. J Hum Hypertens. 2016;30:418–423. PubMed
Oliaei S, SeyedAlinaghi S, Mehrtak M, Karimi A, Noori T, Mirzapour P, et al. The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic review. Eur J Med Res. 2021;26:96. PubMed PMC
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013;19:217–226. PubMed
SeyedAlinaghi S, Karimi A, MohsseniPour M, Barzegary A, Mirghaderi SP, Fakhfouri A, et al. The clinical outcomes of COVID-19 in HIV-positive patients: a systematic review of current evidence. Immun Inflamm Dis. 2021;9:1160–1185. PubMed PMC
Speed V, Patel RK, Byrne R, Roberts LN, Arya R. A perfect storm: root cause analysis of supra-therapeutic anticoagulation with vitamin K antagonists during the COVID-19 pandemic. Thromb Res. 2020;192:73–74. PubMed PMC
Vermeer C, Vik H. Effect of Menaquinone-7 (vitamin K2) on vascular elasticity in healthy subjects: results from a one-year study. Vascul Dis Ther. 2020;5:1–4.
Visser MPJ, Dofferhoff ASM, van den Ouweland JMW, van Daal H, Kramers C, Schurgers LJ, et al. Effects of vitamin D and K on interleukin-6 in COVID-19. Front Nutr. 2021;8 PubMed PMC
Wei FF, Trenson S, Verhamme P, Vermeer C, Staessen JA. Vitamin K-dependent matrix gla protein as multifaceted protector of vascular and tissue integrity. Hypertension. 2019;73:1160–1169. PubMed PMC